Insider Selling: Surgery Partners (NASDAQ:SGRY) Director Sells 20,018 Shares of Stock

Key Points

• Surgery Partners, Inc. Director Teresa Deluca sold 20,018 shares of the company's stock for a total of $455,209.32, reducing her ownership by 30.71% and leaving her with 45,173 shares valued at over $1 million.
• The company recently reported a positive earnings surprise with $0.17 earnings per share, surpassing the consensus estimate of $0.16, alongside a revenue of $826.20 million for the quarter.
• Surgery Partners has attracted attention from analysts, with ratings ranging from "hold" to "buy", and a consensus price target set at $33.00 as research firms adjust their price objectives.

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) Director Teresa Deluca sold 20,018 shares of the company's stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $22.74, for a total value of $455,209.32. Following the sale, the director directly owned 45,173 shares of the company's stock, valued at $1,027,234.02. The trade was a 30.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Surgery Partners Stock Performance

Shares of NASDAQ:SGRY traded up $0.64 during trading on Wednesday, reaching $23.84. The stock had a trading volume of 2,164,502 shares, compared to its average volume of 1,764,944. The stock has a fifty day simple moving average of $22.12 and a two-hundred day simple moving average of $22.94. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 52 week low of $18.87 and a 52 week high of $33.97. The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of -16.67 and a beta of 1.82.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. The business had revenue of $826.20 million during the quarter, compared to the consensus estimate of $816.96 million. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. Surgery Partners's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.21 EPS. As a group, analysts anticipate that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. AlphaQuest LLC lifted its stake in shares of Surgery Partners by 112.0% in the first quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock valued at $25,000 after buying an additional 559 shares during the period. PNC Financial Services Group Inc. increased its stake in Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock valued at $28,000 after acquiring an additional 542 shares during the period. Summit Securities Group LLC acquired a new position in Surgery Partners in the 1st quarter valued at approximately $31,000. DekaBank Deutsche Girozentrale bought a new stake in shares of Surgery Partners in the 1st quarter worth approximately $65,000. Finally, State of Wyoming lifted its position in shares of Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after acquiring an additional 1,943 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on SGRY shares. Bank of America started coverage on Surgery Partners in a research note on Monday, July 28th. They issued a "buy" rating and a $28.00 price objective on the stock. Barclays lowered their target price on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.